MIVI Neuroscience Announces First Patient Enrolled in EVAQ Clinical Study for Ischemic Stroke Treatment ...Middle East

PR Newswire - News
EDEN PRAIRIE, Minn., Dec. 1, 2020 /PRNewswire/ -- MIVI Neuroscience, Inc. announced that it has enrolled the first patient in the Food and Drug Administration approved Investigational Device Exemption EVAQ Clinical Study. The procedure took place at Hôpital de Purpan in Toulouse, France....

Read More Details
Finally We wish PressBee provided you with enough information of ( MIVI Neuroscience Announces First Patient Enrolled in EVAQ Clinical Study for Ischemic Stroke Treatment )

Apple Storegoogle play

Also on site :



Latest News